| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| CVACCureVac N.V. | 1.05B | 4.66 | 6.47 | 8.96% | 37.93% | 33.02% | 7.95% | 0.06 |
| NVAXNovavax, Inc. | 1.67B | 10.14 | 3.93 | 64.69% | 39.19% | |||
| SCNIScinai Immunotherapeutics Ltd. | 3.03B | 0.89 | 0.15 | 401.83% | 58.65% | 0.21 | ||
| TNXPTonix Pharmaceuticals Holding Corp. | 142.05M | 13.97 | -0.08 | 29.94% | -9.63% | -42.93% | 0.04 | |
| INOInovio Pharmaceuticals, Inc. | 65.34M | 1.81 | -0.46 | -73.83% | -592.82% | -115.42% | 0.17 | |
| IVVDInvivyd, Inc. | 362.35M | 1.69 | -1.18 | -119.63% | -64.32% | 0.02 | ||
| SPROSpero Therapeutics, Inc. | 122.2M | 2.17 | -1.71 | -53.77% | -122.56% | -165.46% | 0.09 | |
| AVIRAtea Pharmaceuticals, Inc. | 365.63M | 4.68 | -2.34 | -46.56% | 0.00 |
Analyze head-to-head performance against top industry competitors across valuation, growth, and profitability metrics.
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 15.35M | 31.18M | 34.29M | 18.66M | 22.39M | 197.58M | 1.6B | 556.38M | 682.16M | 1.12B |
| Revenue Growth % | -57.65% | 103.06% | 9.98% | -45.57% | 19.97% | 782.53% | 709.26% | -65.2% | 22.61% | 64.69% |
| Cost of Goods Sold | 237.94M | 0 | 0 | 113.84M | 0 | 0 | 902.64M | 343.77M | 202.74M | 73.04M |
| COGS % of Revenue | 1549.79% | - | - | 610.02% | - | - | 56.45% | 61.79% | 29.72% | 6.5% |
| Gross Profit | -222.59M | 31.18M | 34.29M | -95.18M | 22.39M | 197.58M | 696.31M | 212.61M | 479.42M | 1.05B |
| Gross Margin % | -1449.79% | 100% | 100% | -510.02% | 100% | 100% | 43.55% | 38.21% | 70.28% | 93.5% |
| Gross Profit Growth % | -76.1% | 114.01% | 9.98% | -377.59% | 123.52% | 782.53% | 252.42% | -69.47% | 125.49% | 119.1% |
| Operating Expenses | 284.47M | 202.89M | 208.21M | 148.26M | 439.11M | 1.88B | 1.34B | 779.13M | 728.35M | 499.8M |
| OpEx % of Revenue | 1852.84% | 650.78% | 607.23% | 794.44% | 1961.35% | 953.61% | 83.87% | 140.03% | 106.77% | 44.49% |
| Selling, General & Admin | 46.53M | 34.45M | 34.41M | 34.42M | 145.29M | 298.36M | 488.69M | 468.95M | 337.19M | 157.48M |
| SG&A % of Revenue | 303.05% | 110.5% | 100.35% | 184.42% | 648.96% | 151.01% | 30.56% | 84.28% | 49.43% | 14.02% |
| Research & Development | 237.94M | 168.44M | 173.8M | 113.84M | 747.03M | 2.53B | 1.24B | 737.5M | 391.17M | 342.32M |
| R&D % of Revenue | 1549.79% | 540.27% | 506.87% | 610.02% | 3336.73% | 1282.77% | 77.26% | 132.55% | 57.34% | 30.47% |
| Other Operating Expenses | -31K | 67K | 108K | -13K | -453.21M | -948.71M | -382.92M | -427.32M | 0 | 0 |
| Operating Income | -269.11M | -171.71M | -173.92M | -120.58M | -416.72M | -1.69B | -644.74M | -566.51M | -248.93M | 452.8M |
| Operating Margin % | -1752.84% | -550.78% | -507.23% | -646.13% | -1861.35% | -853.61% | -40.32% | -101.82% | -36.49% | 40.3% |
| Operating Income Growth % | -71.15% | 36.19% | -1.29% | 30.67% | -245.59% | -304.73% | 61.77% | 12.13% | 56.06% | 281.9% |
| EBITDA | -260.61M | -161.89M | -165.76M | -114.78M | -411.83M | -1.67B | -615.68M | -525.29M | -200.44M | 452.8M |
| EBITDA Margin % | -1697.44% | -519.29% | -483.43% | -615.05% | -1839.53% | -847.2% | -38.51% | -94.41% | -29.38% | 40.3% |
| EBITDA Growth % | -72.3% | 37.88% | -2.39% | 30.75% | -258.8% | -306.45% | 63.22% | 14.68% | 61.84% | 325.91% |
| D&A (Non-Cash Add-back) | 8.51M | 9.82M | 8.16M | 5.8M | 4.88M | 12.66M | 29.05M | 41.23M | 48.5M | 0 |
| EBIT | -267M | -169.7M | -172.56M | -119.08M | -403.11M | -1.69B | -633.77M | -528.62M | -156.54M | 0 |
| Net Interest Income | -12.96M | -14.07M | -13.61M | -12.1M | -15.14M | -21.13M | -19.88M | -14.42M | -20.07M | 0 |
| Interest Income | 0 | 0 | 0 | 1.51M | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 12.96M | 14.07M | 12.19M | 13.61M | 15.14M | 21.13M | 19.88M | 14.42M | 20.07M | -22.55M |
| Other Income/Expense | -10.85M | -12.06M | -10.83M | -12.11M | -1.54M | -27.96M | -8.91M | 23.48M | 72.32M | -10.63M |
| Pretax Income | -279.97M | -183.77M | -184.75M | -132.69M | -418.26M | -1.71B | -653.65M | -543.03M | -176.62M | 442.17M |
| Pretax Margin % | -1823.53% | -589.46% | -538.81% | -711.04% | -1868.23% | -867.76% | -40.88% | -97.6% | -25.89% | 39.36% |
| Income Tax | 2.32M | 0 | 1.36M | 0 | 0 | 29.21M | 4.29M | 2.03M | 10.88M | -1.86M |
| Effective Tax Rate % | 100% | 100% | 100% | 98.05% | 100% | 101.7% | 100.66% | 100.37% | 106.16% | 99.58% |
| Net Income | -279.97M | -183.77M | -184.75M | -130.1M | -418.26M | -1.74B | -657.94M | -545.06M | -187.5M | 440.3M |
| Net Margin % | -1823.53% | -589.46% | -538.81% | -697.15% | -1868.23% | -882.55% | -41.15% | -97.97% | -27.49% | 39.19% |
| Net Income Growth % | -78.39% | 34.36% | -0.53% | 29.58% | -221.49% | -316.91% | 62.27% | 17.16% | 65.6% | 334.83% |
| Net Income (Continuing) | -279.97M | -183.77M | -184.75M | -132.69M | -418.26M | -1.74B | -657.94M | -545.06M | -187.5M | 440.3M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -20.68 | -12.56 | -9.99 | -5.40 | -7.43 | -23.44 | -8.42 | -5.41 | -1.23 | 2.58 |
| EPS Growth % | -72.77% | 39.27% | 20.46% | 45.95% | -37.59% | -215.48% | 64.08% | 35.75% | 77.26% | 309.76% |
| EPS (Basic) | -20.68 | -12.56 | -9.99 | -5.40 | -7.43 | -23.44 | -8.42 | -5.41 | -1.23 | 2.72 |
| Diluted Shares Outstanding | 13.54M | 14.63M | 18.49M | 24.1M | 57.55M | 74.4M | 78.18M | 100.77M | 152.19M | 173.1M |
| Basic Shares Outstanding | 13.54M | 14.63M | 18.49M | 24.1M | 57.55M | 74.4M | 78.18M | 100.77M | 152.19M | 161.99M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 287.83M | 203.31M | 119.28M | 97.25M | 1.25B | 2.16B | 1.7B | 1.14B | 1.13B | 978.28M |
| Cash & Short-Term Investments | 144.35M | 106.31M | 70.15M | 78.82M | 711.05M | 1.52B | 1.34B | 568.5M | 923.12M | 735.08M |
| Cash Only | 144.35M | 106.31M | 70.15M | 78.82M | 553.4M | 1.52B | 1.34B | 568.5M | 530.23M | 240.63M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 157.65M | 0 | 0 | 0 | 392.89M | 494.45M |
| Accounts Receivable | 233K | 0 | 0 | 7.5M | 262.01M | 454.99M | 82.38M | 297.24M | 108.28M | 106.45M |
| Days Sales Outstanding | 5.54 | - | - | 146.69 | 4.27K | 840.53 | 18.8 | 195 | 57.94 | 34.58 |
| Inventory | 15.74M | 13.09M | 11.97M | 0 | 0 | 0 | 36.68M | 41.7M | 8.75M | 11.54M |
| Days Inventory Outstanding | 24.14 | - | - | - | - | - | 14.83 | 44.27 | 15.75 | 57.69 |
| Other Current Assets | 20.65M | 19.84M | 3.19M | 7.32M | 103.54M | 56.11M | 86.68M | 166.15M | 32.51M | 125.2M |
| Total Non-Current Assets | 106.47M | 99.18M | 88.7M | 75.71M | 334.28M | 421.63M | 555.29M | 653.6M | 431.48M | 198.24M |
| Property, Plant & Equipment | 40.18M | 35.99M | 28.43M | 11.45M | 179.95M | 228.7M | 400.49M | 490.99M | 300M | 67.7M |
| Fixed Asset Turnover | 0.38x | 0.87x | 1.21x | 1.63x | 0.12x | 0.86x | 3.99x | 1.13x | 2.27x | 16.60x |
| Goodwill | 51.67M | 53.56M | 51.97M | 51.15M | 135.38M | 131.48M | 126.33M | 127.45M | 107.48M | 113.46M |
| Intangible Assets | 9.22M | 7.87M | 6.54M | 5.58M | 5.72M | 4.77M | 0 | 0 | 0 | 0 |
| Long-Term Investments | 4.59M | 890K | 958K | 410K | 0 | 1.65M | 1.66M | 0 | 0 | 0 |
| Other Non-Current Assets | 5.39M | 1.76M | 1.77M | 7.53M | 13.22M | 56.69M | 28.47M | 35.16M | 24M | 17.08M |
| Total Assets | 394.3M | 302.49M | 207.98M | 172.96M | 1.58B | 2.58B | 2.26B | 1.8B | 1.56B | 1.18B |
| Asset Turnover | 0.04x | 0.10x | 0.16x | 0.11x | 0.01x | 0.08x | 0.71x | 0.31x | 0.44x | 0.95x |
| Asset Growth % | 2.14% | -23.28% | -31.25% | -16.84% | 814.96% | 62.83% | -12.34% | -20.42% | -13.19% | -24.6% |
| Total Current Liabilities | 66.41M | 73.67M | 45.54M | 25.8M | 579.67M | 2.39B | 2.46B | 1.64B | 1.15B | 459.95M |
| Accounts Payable | 5.68M | 5.61M | 9.3M | 2.91M | 54.33M | 127.05M | 216.52M | 132.61M | 41.58M | 24.58M |
| Days Payables Outstanding | 8.72 | - | - | 9.33 | - | - | 87.55 | 140.8 | 74.86 | 122.82 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 324.88M | 0 | 0 | 2.51M |
| Deferred Revenue (Current) | 30.08M | 25.63M | 10.01M | 1.68M | 273.23M | 1.42B | 370.14M | 241.31M | 675.07M | 140.05M |
| Other Current Liabilities | 23.34M | 31.25M | 16.6M | 12.44M | 29.61M | 74.48M | 982.62M | 917.36M | 279.95M | 317.39M |
| Current Ratio | 4.33x | 2.76x | 2.62x | 3.77x | 2.15x | 0.90x | 0.69x | 0.70x | 0.98x | 2.13x |
| Quick Ratio | 4.10x | 2.58x | 2.36x | 3.77x | 2.15x | 0.90x | 0.68x | 0.67x | 0.97x | 2.10x |
| Cash Conversion Cycle | 20.96 | - | - | - | - | - | -53.92 | 98.47 | -1.17 | -30.55 |
| Total Non-Current Liabilities | 333.44M | 330.55M | 330.37M | 333.18M | 375.6M | 538.11M | 432.81M | 879.28M | 1.03B | 844.32M |
| Long-Term Debt | 316.34M | 317.76M | 319.19M | 320.61M | 322.04M | 323.46M | 166.47M | 168.02M | 169.68M | 246.3M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 40.08M | 0 | 31.24M | 55.92M | 53.73M | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 14.6M | 10.29M | 8.69M | 10.07M | 13.48M | 42.12M | 55.7M | 33.13M | 359.61M | 598.01M |
| Total Liabilities | 399.85M | 404.23M | 375.91M | 358.97M | 955.27M | 2.93B | 2.89B | 2.51B | 2.18B | 1.3B |
| Total Debt | 316.34M | 317.76M | 319.19M | 321.87M | 467.98M | 453.99M | 549.78M | 229.08M | 230.42M | 248.81M |
| Net Debt | 171.99M | 211.46M | 249.03M | 243.05M | -85.42M | -1.06B | -787.1M | -339.42M | -299.81M | 8.18M |
| Debt / Equity | - | - | - | - | 0.75x | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | 0.55x |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | 0.02x |
| Interest Coverage | -20.76x | -12.20x | -14.27x | -8.86x | -27.52x | -79.83x | -32.43x | -39.30x | -12.40x | - |
| Total Equity | -5.55M | -101.73M | -167.94M | -186.02M | 627.21M | -351.67M | -634.08M | -716.93M | -623.84M | -127.75M |
| Equity Growth % | -101.89% | -1734.33% | -65.08% | -10.77% | 437.18% | -156.07% | -80.3% | -13.07% | 12.98% | 79.52% |
| Book Value per Share | -0.41 | -6.95 | -9.08 | -7.72 | 10.90 | -4.73 | -8.11 | -7.11 | -4.10 | -0.74 |
| Total Shareholders' Equity | -5.55M | -101.73M | -167.94M | -186.02M | 627.21M | -351.67M | -634.08M | -716.93M | -623.84M | -127.75M |
| Common Stock | 2.72M | 3.24M | 3.85M | 324K | 714K | 764K | 868K | 1.41M | 1.62M | 1.65M |
| Retained Earnings | -930M | -1.11B | -1.3B | -1.43B | -1.87B | -3.62B | -4.28B | -4.82B | -5.01B | -4.57B |
| Treasury Stock | -2.45M | -2.45M | -2.45M | -2.58M | -41.81M | -85.1M | -90.66M | -92.27M | -95.85M | 0 |
| Accumulated OCI | -11.81M | -8.62M | -11.19M | -12.51M | 7.02M | -1.35M | -6.38M | 2.72M | -22.56M | 2.01M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -255.47M | -138.7M | -184.82M | -136.62M | -42.54M | 322.95M | -415.94M | -713.97M | -87.26M | -244.63M |
| Operating CF Margin % | -1663.95% | -444.88% | -539.04% | -732.09% | -190.02% | 163.45% | -26.01% | -128.32% | -12.79% | -21.77% |
| Operating CF Growth % | -102.61% | 45.71% | -33.26% | 26.08% | 68.86% | 859.14% | -228.79% | -71.65% | 87.78% | -180.34% |
| Net Income | -279.97M | -183.77M | -184.75M | -132.69M | -418.26M | -1.74B | -657.94M | -545.06M | -187.5M | 440.3M |
| Depreciation & Amortization | 8.51M | 9.82M | 8.16M | 5.68M | 4.88M | 12.66M | 29.05M | 41.23M | 48.5M | 27.61M |
| Stock-Based Compensation | 19.16M | 19.81M | 18.31M | 17.05M | 128.03M | 183.63M | 130.3M | 85.36M | 48.15M | 36.02M |
| Deferred Taxes | 374K | 269K | -55K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 3.93M | 6.07M | -5.35M | -2.63M | 230.78M | 136.79M | 443.8M | 81.35M | -44.89M | -748.57M |
| Working Capital Changes | -7.47M | 9.11M | -21.14M | -24.02M | 12.02M | 1.73B | -361.15M | -376.84M | 48.48M | 0 |
| Change in Receivables | 2.07M | 0 | 1.21M | -4.2M | -422.69M | -192.26M | 249.17M | -274.44M | 354.09M | 61.04M |
| Change in Inventory | -1.98M | 0 | 0 | 0 | 0 | -600.33M | -477.8M | -74.46M | 12.91M | -3.24M |
| Change in Payables | -4.81M | 5.19M | -6.74M | 0 | 163.16M | 600.33M | 913.4M | -378.81M | -385.63M | -322.57M |
| Cash from Investing | 28.02M | 35.97M | 28.6M | 38.49M | -377.78M | 100.15M | -92.98M | -58.81M | -204.04M | -78.27M |
| Capital Expenditures | -18.21M | -4.19M | -1.37M | -1.86M | -54.62M | -57.49M | -92.98M | -58.81M | -14.64M | -5.56M |
| CapEx % of Revenue | 118.63% | 13.44% | 4% | 9.95% | 243.98% | 29.09% | 5.82% | 10.57% | 2.15% | 0.49% |
| Acquisitions | 18.21M | 4.19M | 1.37M | 0 | -165.52M | 57.49M | 0 | 0 | 192.64M | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -18.2M | -4.19M | -1.37M | 18.33M | 0 | -57.49M | 0 | 0 | 0 | 18.82M |
| Cash from Financing | 279.03M | 64.54M | 102.81M | 98.38M | 984.76M | 461.71M | 324.99M | 4.47M | 260.58M | 27.74M |
| Debt Issued (Net) | 324.53M | -37K | 0 | 0 | -96.06M | -127.91M | 81.66M | -352.35M | -3.99M | 0 |
| Equity Issued (Net) | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -49.31M | 1.15M | 2.75M | 992K | 5.38M | 24.76M | -5.9M | -3.59M | 1.3M | 27.74M |
| Net Change in Cash | 51.24M | -38.05M | -53.47M | 221K | 566.56M | 879.52M | -179.41M | -765.03M | -38.52M | -289.24M |
| Free Cash Flow | -273.68M | -142.88M | -186.2M | -138.48M | -97.16M | 265.46M | -508.92M | -772.77M | -100.32M | -250.19M |
| FCF Margin % | -1782.58% | -458.32% | -543.04% | -742.04% | -434% | 134.35% | -31.83% | -138.89% | -14.71% | -22.27% |
| FCF Growth % | -89.56% | 47.79% | -30.31% | 25.63% | 29.84% | 373.21% | -291.71% | -51.85% | 87.02% | -149.4% |
| FCF per Share | -20.21 | -9.76 | -10.07 | -5.75 | -1.69 | 3.57 | -6.51 | -7.67 | -0.66 | -1.45 |
| FCF Conversion (FCF/Net Income) | 0.91x | 0.75x | 1.00x | 1.05x | 0.10x | -0.19x | 0.63x | 1.31x | 0.47x | -0.56x |
| Interest Paid | 0 | 0 | 0 | 12.19M | 13.71M | 19.43M | 18.04M | 17.35M | 17.57M | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 12.61M | 17.98M | 190K | 949K | 0 |
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -195.01% | - | - | - | -189.6% | -1265.72% | - | - | - | - |
| Return on Invested Capital (ROIC) | -110.17% | -93.27% | -136.71% | -130.94% | -104.38% | - | - | - | - | - |
| Gross Margin | -1449.79% | 100% | 100% | -510.02% | 100% | 100% | 43.55% | 38.21% | 70.28% | 93.5% |
| Net Margin | -1823.53% | -589.46% | -538.81% | -697.15% | -1868.23% | -882.55% | -41.15% | -97.97% | -27.49% | 39.19% |
| Debt / Equity | - | - | - | - | 0.75x | - | - | - | - | - |
| Interest Coverage | -20.76x | -12.20x | -14.27x | -8.86x | -27.52x | -79.83x | -32.43x | -39.30x | -12.40x | - |
| FCF Conversion | 0.91x | 0.75x | 1.00x | 1.05x | 0.10x | -0.19x | 0.63x | 1.31x | 0.47x | -0.56x |
| Revenue Growth | -57.65% | 103.06% | 9.98% | -45.57% | 19.97% | 782.53% | 709.26% | -65.2% | 22.61% | 64.69% |
Explore detailed financial history, valuation models, and returns analysis
DCF models, peer multiples & analyst estimates
Historical returns with dividends reinvested
Yield, growth, payout safety & DRIP calculator
EPS trends, net income & profitability analysis
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of valuation, profitability & efficiency metrics